High expression of CDKN2A is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy. Dong Y, Zheng M, Wang X, Yu C, et al. BMC Cancer 2023;23:1097.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dong Y, Zheng M, Wang X, Yu C, et al. High expression of CDKN2A is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy. BMC Cancer 2023;23:1097.
PMID: 37950153